TOPLINE: Patients with moderate to severe psoriasis treated with ustekinumab and guselkumab showed a trend towards a lower risk for herpes zoster (HZ) and postherpetic neuralgia (PHN) than those receiving traditional systemic treatments. Adalimumab was associated with a significantly higher risk for HZ. METHODOLOGY: Researchers conducted a retrospective cohort study of patients with psoriasis or […]
The post HZ Risk With Psoriasis Biologics, Traditional Rxs Compared first appeared on News Health.
Author : News Health
Publish date : 2025-03-28 10:33:00
Copyright for syndicated content belongs to the linked Source.